ICON (IJF) Stock Overview

A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. More details

IJF fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	1/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 42.8% below our estimate of its fair value

Earnings are forecast to grow 18.63% per year

Risk Analysis

Shares are highly illiquid

Profit margins (2.8%) are lower than last year (9%)

Large one-off items impacting financial results

IJF Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

ICON Public Limited Company Competitors

Price History & Performance

Summary of share price highs, lows and changes for ICON
Historical stock prices
Current Share Price	US$128.93
52 Week High	US$0
52 Week Low	US$0
Beta	1.27
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-23.49%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	IJF	DE Life Sciences	DE Market
7D	n/a	-2.7%	-2.9%
1Y	n/a	-6.7%	-0.8%

Return vs Industry: Insufficient data to determine how IJF performed against the German Life Sciences industry.

Return vs Market: Insufficient data to determine how IJF performed against the German Market.

Price Volatility

Is IJF's price volatile compared to industry and market?
IJF volatility
IJF Average Weekly Movement	n/a
Life Sciences Industry Average Movement	8.6%
Market Average Movement	5.9%
10% most volatile stocks in DE Market	13.0%
10% least volatile stocks in DE Market	2.7%

Stable Share Price: IJF's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine IJF's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1989	40,100	Barry Balfe	www.iconplc.com

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization.

ICON Public Limited Company Fundamentals Summary

How do ICON's earnings and revenue compare to its market cap?
IJF fundamental statistics
Market cap	€10.10b
Earnings (TTM)	€198.68m
Revenue (TTM)	€7.15b

50.7x

P/E Ratio

1.4x

P/S Ratio

Is IJF overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IJF income statement (TTM)
Revenue	US$8.25b
Cost of Revenue	US$6.07b
Gross Profit	US$2.18b
Other Expenses	US$1.95b
Earnings	US$229.34m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	3.00
Gross Margin	26.44%
Net Profit Margin	2.78%
Debt/Equity Ratio	37.0%

How did IJF perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/09 05:19
End of Day Share Price	2026/06/09 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ICON Public Limited Company is covered by 30 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Eric Coldwell	Baird
Luke Sergott	Barclays
Douglas Tsao	Barclays